EndoCare Therapeutics
EndoCare Therapeutics is an early-stage company focused on advancing endometriosis diagnosis through a sensitive, non-invasive, and cost-effective diagnostic tool that utilizes molecular methods and artificial intelligence with deep learning. Their mission is to improve the lives of millions of women globally affected by this chronic disease by providing innovative healthcare solutions. The company adopts a patient-centric approach, emphasizing ingenuity and affordability. They aim to develop a comprehensive panel of biomarkers for early and accurate diagnosis. The company was founded in 2023 and is currently in pre-clinical testing, with plans for prototype development, clinical trials, and market commercialization by 2027. They also engage in endometriosis advocacy to raise awareness and improve access to care.
EndoCare Therapeutics
EndoCare Therapeutics is an early-stage company focused on advancing endometriosis diagnosis through a sensitive, non-invasive, and cost-effective diagnostic tool that utilizes molecular methods and artificial intelligence with deep learning. Their mission is to improve the lives of millions of women globally affected by this chronic disease by providing innovative healthcare solutions. The company adopts a patient-centric approach, emphasizing ingenuity and affordability. They aim to develop a comprehensive panel of biomarkers for early and accurate diagnosis. The company was founded in 2023 and is currently in pre-clinical testing, with plans for prototype development, clinical trials, and market commercialization by 2027. They also engage in endometriosis advocacy to raise awareness and improve access to care.